Dr. Mark Denison will serve as a co-principal investigator and steering committee member for the NIH-funded bioterrorism defense consortium. Dana Johnson
The first Vanderbilt-Meharry Center for AIDS Research Symposium will be held Wednesday, Sept. 10 from 8 a.m. to 2 p.m. at the University Club at Vanderbilt. “HIV Prevention, Pathogenesis, and Treatment: Interactions Between Virus and Host,” will feature some of the most renowned HIV researchers in the U.S. and abroad. Topics include:
•“HIV Adaptation to its Human Hosts: Can HLA Diversity be Exploited and the Problem of HIV Diversity be Overcome for Vaccine Development and Treatment Optimization?” Dr. Simon Mallal, professor and executive director at the Center for Clinical Immunology and Biomedical Statistics, Perth, Australia, and Pfizer Visiting Professor at Vanderbilt.
•“Development of a Globally Relevant HIV Vaccine.” Dr. Barney Graham, chief of the Viral Pathogenesis Laboratory and Clinical Trials Core at the Vaccine Research Center, National Institutes of Health.
•“HIV Entry and Chemokine Receptors: Implications for Antiretroviral Therapy.” Dr. Robert Doms, chair, Department of Microbiology, the University of Pennsylvania, Philadelphia.
•“HIV as Trojan Exosome: Implications for Pathogenesis and Vaccines.” Dr. James Hildreth, professor of Pharmacology and Molecular Sciences and director of the Monoclonal Antibody Core at the Center For AIDS Research, Johns Hopkins University School of Medicine.
•“HIV Reloaded: How the Virus Exploits and Remodels the Matrix of Immune Systems.” Dr. Derya Unutmaz, assistant professor of Microbiology and Immunology, Vanderbilt University Medical Center.
The symposium is co-sponsored by the Vanderbilt-Meharry Center for AIDS Research in partnership with the Tennessee AIDS Education and Training Center.
There is no charge for registration or parking, and lunch is included, but those wishing to attend should RSVP today to Brent Meredith at 322-8972 or brent.meredith@vanderbilt.edu.